Skip to content
HowShorted

Prestige Consumer Healthcare Inc. short interest in 2026

In 2026, Prestige Consumer Healthcare Inc.'s disclosed short interest ran from 4.31% of shares outstanding on 15 Jan 2026 to 10.12% on 15 Sep 2026, a change of +5.81 percentage points. The year's high was 10.12% on 15 Sep 2026 and its low 4.25% on 13 Feb 2026, averaging 6.32% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.05 days on 31 Aug 2026. Full history: Prestige Consumer Healthcare Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Prestige Consumer Healthcare Inc. in 2026

2026 in figures

Start of year
4.31% (15 Jan 2026)
End of year
10.12% (15 Sep 2026)
Change
+5.81 pp
High
10.12% (15 Sep 2026)
Low
4.25% (13 Feb 2026)
Average
6.32%
Highest days to cover
11.05 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Prestige Consumer Healthcare Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20264.31%6.68
30 Jan 20264.62%5.47
13 Feb 20264.25%4.5710-Q filed, results (8-K)
27 Feb 20265.02%5.11
13 Mar 20265.28%6.44
31 Mar 20265.69%5.08
15 Apr 20264.86%3.48
30 Apr 20266.17%6.68
15 May 20265.67%2.78results (8-K), 10-K filed
29 May 20265.23%3.38
15 Jun 20266.19%4.59
30 Jun 20266.78%3.52
15 Jul 20266.52%6.65
31 Jul 20268.06%8.10
14 Aug 20269.01%6.2210-Q filed, results (8-K)
31 Aug 20269.68%11.05
15 Sep 202610.12%9.45

See also: Prestige Consumer Healthcare Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.